Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,917 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Role of flow cytometry immunophenotyping in the diagnosis of leptomeningeal carcinomatosis.
Subirá D, Serrano C, Castañón S, Gonzalo R, Illán J, Pardo J, Martínez-García M, Millastre E, Aparisi F, Navarro M, Dómine M, Gil-Bazo I, Pérez Segura P, Gil M, Bruna J. Subirá D, et al. Among authors: gil m, gil bazo i. Neuro Oncol. 2012 Jan;14(1):43-52. doi: 10.1093/neuonc/nor172. Epub 2011 Oct 12. Neuro Oncol. 2012. PMID: 21993441 Free PMC article.
Patterns of care and outcome for patients with glioblastoma diagnosed during 2008-2010 in Spain.
Graus F, Bruna J, Pardo J, Escudero D, Vilas D, Barceló I, Brell M, Pascual C, Crespo JA, Erro E, García-Romero JC, Estela J, Martino J, García-Castaño A, Mata E, Lema M, Gelabert M, Fuentes R, Pérez P, Manzano A, Aguas J, Belenguer A, Simón A, Henríquez I, Murcia M, Vivanco R, Rojas-Marcos I, Muñoz-Carmona D, Navas I, de Andrés P, Mas G, Gil M, Verger E. Graus F, et al. Among authors: gil m. Neuro Oncol. 2013 Jun;15(6):797-805. doi: 10.1093/neuonc/not013. Epub 2013 Mar 3. Neuro Oncol. 2013. PMID: 23460319 Free PMC article.
Extended-schedule dose-dense temozolomide in refractory gliomas.
Berrocal A, Perez Segura P, Gil M, Balaña C, Garcia Lopez J, Yaya R, Rodríguez J, Reynes G, Gallego O, Iglesias L; GENOM Cooperative Group. Berrocal A, et al. Among authors: gil m. J Neurooncol. 2010 Feb;96(3):417-22. doi: 10.1007/s11060-009-9980-7. Epub 2009 Aug 8. J Neurooncol. 2010. PMID: 19669096 Free PMC article. Clinical Trial.
Bevacizumab plus irinotecan in recurrent malignant glioma shows high overall survival in a multicenter retrospective pooled series of the Spanish Neuro-Oncology Research Group (GEINO).
Gil MJ, de Las Peñas R, Reynés G, Balañá C, Peréz-Segura P, García-Velasco A, Mesia C, Gallego O, Fernández-Chacón C, Martínez-García M, Herrero A, Andrés R, Benavides M, Quintanar T, Pérez-Martin X. Gil MJ, et al. Anticancer Drugs. 2012 Jul;23(6):659-65. doi: 10.1097/CAD.0b013e3283534d3e. Anticancer Drugs. 2012. PMID: 22634799
SEOM guideline for the treatment of malignant glioma.
Berrocal A, Gil M, Gallego Ó, Balaña C, Pérez Segura P, García-Mata J, Reynes G; SEOM (Spanish Society of Clinical Oncology). Berrocal A, et al. Among authors: gil m. Clin Transl Oncol. 2012 Jul;14(7):545-50. doi: 10.1007/s12094-012-0839-6. Clin Transl Oncol. 2012. PMID: 22721801
1,917 results